anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
AstraZeneca · conference-presentation

AstraZeneca | Investor Conference Presentation Deck | 26 slides

26 pages · 5 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

AstraZeneca | Investor Conference Presentation Deck | 26 slides

AstraZeneca · 2024-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 21 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Humble Origins 3 slides 100% 3/3 slides 100% 3/3 slides · 17 hits
— 0/3 slides
66.7% 2/3 slides
— 0/3 slides
100% 3/3 slides
— 0/3 slides
Early Struggles 3 slides 100% 3/3 slides 100% 3/3 slides · 21 hits
— 0/3 slides
66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides Rising Success 8 slides 100% 8/8 slides 100% 8/8 slides · 53 hits
— 0/8 slides
50% 4/8 slides 12.5% 1/8 slides 100% 8/8 slides 37.5% 3/8 slides The Breakthrough 3 slides 100% 3/3 slides 100% 3/3 slides · 16 hits
— 0/3 slides
66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides Ultimate Achievement 4 slides 100% 4/4 slides 100% 4/4 slides · 25 hits
— 0/4 slides
50% 2/4 slides 25% 1/4 slides 100% 4/4 slides
— 0/4 slides

Slide inventory

26
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Humble Origins
02
other
Open slide detailBeat · Humble Origins
03
The slide uses a combination of big numbers, process diagrams for strategy, and a mix of donut and bar charts for revenue analysis.analyze_data
Open slide detailBeat · Humble Origins
04
The slide uses a horizontal layout to segment the business into five pillars, each with specific growth drivers and outlooks.summarize
Open slide detailBeat · Early StrugglesLoop · Logic Chain
05
The right-hand side is a complex matrix mapping clinical trials to patient segments (HER2-positive, HR-positive, TNBC, gBRCAm) and treatment stages (Neoadjuvantsummarize
Open slide detailBeat · Early StrugglesLoop · Logic Chain
06
The slide uses a structured grid to map corporate acquisitions/partnerships to strategic goals and therapeutic areas.summarize
Open slide detailBeat · Early StrugglesLoop · Logic Chain
07
transition
Open slide detailBeat · Rising SuccessLoop · Logic Chain
08
The slide uses a structured layout to present the company's oncology portfolio, categorizing drugs by their therapeutic focus and market position.summarize
Open slide detailBeat · Rising SuccessLoop · Logic Chain
09
Includes specific drug names and market projections for 2028.size_opportunity
Open slide detailBeat · Rising SuccessLoop · Logic Chain
10
The slide features a scientific illustration of cellular interaction on the left and the business unit name with icons on the right.transition
Open slide detailBeat · Rising Success
11
The slide uses a three-column layout to categorize business units and their respective growth drivers.summarize
Open slide detailBeat · Rising Success
12
NME stands for New Molecular Entity. FDC stands for Fixed-Dose Combination.size_opportunity
Open slide detailBeat · Rising Success
13
Includes clinical development pipeline visualization and market growth projections.summarize
Open slide detailBeat · Rising Success
14
Includes a table comparing hospitalization rates for RSV, hMPV, and Influenza across age groups.quantify_opportunity
Open slide detailBeat · Rising Success
15
transition
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
16
The slide uses a waterfall-style growth diagram for Ultomiris and a combination of bar charts and bulleted metrics for HPP assets.size_opportunity
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
17
The slide uses a split layout: left side details specific drug assets (anselamimab, ALXN2220) with clinical stage data, right side outlines the genomic medicinepresent_solution
Open slide detailBeat · The BreakthroughLoop · Cost Of Inaction
18
state_next_steps
Open slide detailBeat · Ultimate Achievement
19
The slide highlights both internal R&D focus areas and external acquisitions (Cellectis, Quell, Gracell) to support long-term growth.plan_implementation
Open slide detailBeat · Ultimate Achievement
20
Includes specific targets for 2025, 2026, and 2030.summarize
Open slide detailBeat · Ultimate Achievement
21
The slide uses a four-column layout to highlight key strategic pillars.summarize
Open slide detailBeat · Ultimate Achievement
22
appendix
Open slide detail
23
appendix
Open slide detail
24
appendix
Open slide detail
25
other
Open slide detail
26
other
Open slide detail